Cucumis sativus (Cucurbitaceae) seed oil prevents benzo(a)pyrene-induced prostate cancer in vitro and in vivo.


Journal

Environmental toxicology
ISSN: 1522-7278
Titre abrégé: Environ Toxicol
Pays: United States
ID NLM: 100885357

Informations de publication

Date de publication:
Sep 2023
Historique:
revised: 26 04 2023
received: 19 10 2022
accepted: 01 05 2023
medline: 9 8 2023
pubmed: 13 6 2023
entrez: 13 6 2023
Statut: ppublish

Résumé

Despite enormous progress in modern medicine, prostate cancer (PCa) remains a major public health problem due to its high incidence and mortality. Although studies have shown in vitro antitumor effects of cucurbitacins from Cucumis sativus, the in vivo anticancer effect of the seed oil as a whole, has yet to be demonstrated. The present study evaluated the in vitro anticancer mechanisms of C. sativus (CS) seed oil and its possible chemopreventive potential on benzo(a)pyrene (BaP)-induced PCa in Wistar rat. In vitro cell growth, clone formation, cell death mechanism, cell adhesion and migration as well as expression of integrins β-1 and β-4 were assessed. In vivo PCa was induced in 56 male rats versus 8 normal control rats, randomized in normal (NOR) and negative (BaP) control groups which, received distilled water; the positive control group (Caso) was treated with casodex (13.5 mg/kg BW). One group received the total seed extract at the dose of 500 mg/kg BW; while the remaining three groups were treated with CS seed oil at 42.5, 85, and 170 mg/kg BW. The endpoints were: morphologically (prostate tumor weight and volume), biochemically (total protein, prostate specific antigen (PSA), oxidative stress markers such as MDA, GSH, catalase, and SOD) and histologically. As results, CS seed oil significantly and concentration-dependently reduced the DU145 prostate cancer cell growth and clone formation (optimum = 100 μg/mL). It slightly increased the number of apoptotic cells and inhibited the migration and invasion of DU145 cells, while it decreased their adhesion to immobilized collagen and fibrinogen. The expression of integrin β-1 and β-4 was increased in presence of 100 μg/mL CS oil. In vivo, the BaP significantly elevated the incidence of PC tumors (75%), the total protein and PSA levels, pro-inflammatory cytokines (TNF-α, IL-1, and IL-6) and MDA levels compared to NOR. CS seeds oil significantly counteracted the effect of BaP by decreasing significantly the PC incidence (12.5%), and increasing the level of antioxidant (SOD, GSH, and catalase) and anti-inflammatory cytokine IL-10 in serum. While in BaP group PCa adenocarninoma was the most representative neoplasm, rats treated with 85 and 170 mg/kg prevented it in the light of the casodex. It is conclude that CS may provide tumor suppressive effects in vitro and in vivo which makes it an interesting candidate to support the current treatment protocol.

Identifiants

pubmed: 37310102
doi: 10.1002/tox.23830
doi:

Substances chimiques

Benzo(a)pyrene 3417WMA06D
bicalutamide A0Z3NAU9DP
Catalase EC 1.11.1.6
Prostate-Specific Antigen EC 3.4.21.77
Cytokines 0
Superoxide Dismutase EC 1.15.1.1
Plant Oils 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2069-2083

Subventions

Organisme : Deutscher Akademischer Austauschdienst
ID : PKZ 91745282

Informations de copyright

© 2023 Wiley Periodicals LLC.

Références

Barsouk A, Padala SA, Vakiti A, et al. Epidemiology, staging and management of prostate cancer. J Med Sci. 2020;8:1-13.
Habib A, Jaffar G, Khalid MS, et al. Risk factors associated with prostate cancer. J Drug Deliv Ther. 2021;11:188-193.
Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radical Biol Med J. 2010;49:1603-1616.
Brand LJ, Dehm SM. Androgen receptor gene rearrangements: new perspectives on prostate cancer progression. Curr Drug Targets. 2013;14:441-449.
Messner EA, Steele TM, Tsamouri MM, et al. The androgen receptor in prostate cancer: effect of structure, ligands and spliced variants on therapy. Biomedicine. 2020;8:1-19.
Dun MW, Kazer MW. Prostate cancer overview. Semin Oncol Nurs. 2011;27:241-250.
Litwin MS, Tan HJ. The diagnosis and treatment of prostate cancer: a review. JAMA. 2017;317:2532-2542.
Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultra sound guided transrectal core biopsies of the prostate. J Urol. 2009;142:71-74.
Njamen D, Bakam Y, Rutz J, et al. Irvingia excelsa Mildbr. ethanolic extract displays in vitro cytotoxic effects on prostate cancer cells and prevents benign prostatic hyperplasia in Wistar rats. Biologia. 2020;75:2053-2062.
Block K, Gyllenhaal C, Lowe L, Amedei A, Ruhul AR, Amin A. Designing a broad-spectrum integrative approach for cancer prevention and treatment. Semin Cancer Biol. 2015;35:276-304. doi:10.1016/j.semcancer.2015.09.007
Bishayee A, Gautam S. Bioactive natural products in cancer prevention and therapy: Progress and promise. Semin Cancer Biol. 2016;40-41:1-3. doi:10.1016/j.semcancer.2016.08.006
Haque A, Brazeau D, Amin R. Perspectives on natural compounds in chemoprevention and treatment of cancer: an update with new promising compounds. Eur J Cancer. 2011;149:165-183. doi:10.1016/j.ejca.2021.03.009
Hostettmann K, Terreaux C. Search for new lead compounds from higher plants. Chimia. 2000;54:652-657.
Hostettmann K, Wolfender J-L. The search for biologically active secondary metabolites. Pestic Sci. 1997;51:471-482.
Sahayi M, Shirali S. Study of Cucurbita extract effect on changes of AGEs, lipid and glycemic profile and CRP in type 1diabetics rats. Bang J Med Sci. 2018;17:84-87.
Tuama AA, Mohammed AA. Phytochemical screening and in vitro antibacterial and anticancer activities of the aqueous extract of Cucumis sativus. Saudi J Biol Sci. 2019;26:600-604.
Lemus-Mondaca R, Marin J, Rivas J, et al. A review of functional attributes and by products. Rev Child Nutr. 2019;46:783-791.
McCormick DL, Rao KV. Chemoprevention of hormone-dependent prostate cancer in the Wistar-Unilever rat. Euro Urol. 1999;35:464-446.
Nahata A, Dixit V. Ameliorative effects of Stinging Nettle (Urtica dioica) on testosterone induced prostatic hyperplasia in rats. Andrologia. 2012;44:396-409.
Rahul K, Manisha B, Vijay R. Inhibitory effects by ayurvedic plants on prostate enlargement induced in rats. Pharmacogn Res. 2014;6:127-132.
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
Wilbur K, Bernhein F, Shapiro O. Determination of lipid peroxydation. Arch Biochem Biophys. 1949;24:3959-3964.
Sinha K. Colorimetric essay of catalase. Anal Biochem. 1972;47:389-394.
Misra H, Fridovish I. Determination of the level of superoxide dismutase in whole blood. Yale University Press; 1972:101-109.
Ellman G. Tissue sulfhydryl group. Arch Biochem Biophys. 1959;82:70-77.
Nilsson O, Peter A, Andersson I, Nilsson K, Grundstrom B, Karlsson B. Antigenic determinants of prostate-specific antigen (PSA) and development of assays specificfor different forms of PSA. Br J Cancer. 1997;75:789-797.
Wu D, Wang Z, Lin M, et al. In Vitro and In Vivo antitumor activity of cucurbitacin C, a novel natural product from cucumber. Front Pharmacol. 2019;10:1-13.
Qing Z, Shi Y, Han L, et al. Identification of seven undescribed cucurbitacins in Cucumis sativus (cucumber) and their cytotoxic activity. Phytochemistry. 2022;197:113-123.
Chang YM, Shih YL, Chen CP, et al. Ouabain induces apoptotic cell death in human prostate DU 145 cancer cells through DNA damage and TRAIL pathways. Environ Toxicol. 2019;34:1329-1339.
Entschladen F, Theodore L, Drell I, Lang K, Joseph J, Zaenker KS. Tumour-cell migration, invasion and metastasis: navigation by neurotransmitters. Lancet. 2004;5:254-258.
Song J, Liu H, Li Z, Yang C, Wang C. Cucurbitacin I inhibits cell migration and invasion and enhances chemosensitivity in colon cancer. Oncol Rep. 2015;26:1867-1871.
Eldaly E, Hussein M, El-Gaml A, El-hefny D, Mishref M. Polycyclic aromatic hydrocarbons (PAHs) in charcoal grilled meat (kebab) and kofta and the effect of marinating on their existence. Zagazig Vet J. 2016;44:40-47.
Islam J, Shree A, Afzal SM, Vafa A, Sultana S. Protective effect of Diosmin against benzo(a)pyrene-induced lung injury in Swiss Albino Mice. Environ Toxicol. 2020;35:747-757.
Arroyo-Acevedo J, Herrera-Calderón O, Chávez-Asmat R, Anampa-Guzmán A, Chumpitaz-Cerrate V, Enciso-Roca E. Protective effect of Chuquiraga spinosa extract on N-methyl-nitrosourea (NMU) induced prostate cancer in rats. Prostate Int. 2017;5:47-52.
Pollak M. The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat Rev Cancer. 2012;12:159-169.
Wang ZA, Mitrofanova A, Bergren SK, et al. Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity. Nat Cell Biol. 2013;15:274-283.
Murray TB. The pathogenesis of prostate cancer. Exon Publications; 2021:29-41.
Montironi R, Mazzucchelli R, Algaba F, Lopez-Beltran A. Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance. J Clin Pathol. 2000;53:655-665.
Miller DR. The role of ROS in the progression and treatment of castration-resistant prostate cancer [thesis]. University of Nebraska Medical Center; 2019:135p.
Klaunig JE, Wang Z, Pu X, Zhou S. Oxidative stress and oxidative damage in chemical carcinogenesis. Toxicol Appl Pharmacol. 2011;254:86-99.
Sharmila G, Athirai T, Kiruthiga B, et al. Chemopreventive effect of quercetin in MNU and testosterone induced prostate cancer of Sprague-Dawley rats. Nutr Cancer. 2014;66:38-46.
Ramezani M, Hasani M, Ramezani F, Abdolmaleki MK. Cucurbitacins: a focus on cucurbitacin E as A natural product and their biological activities. J Pharm Sci. 2021;27:1-13.
Wahid S, Alqahtani A, Khan RA. Analgesic and anti-inflammatory effects and safety profile of Cucurbita maxima and Cucumis sativus seeds. Saudi J Biol Sci. 2021;28:4334-4341.
Berti FCB, De Oliveira KB. IL-10 in cancer: Just a classical immunosuppressive factor or also an immunostimulatingone? AIMS Allerg Immunol. 2018;2:88-97.
Bouraoui Y, Ricote M, García-Tuñón I, et al. Pro-inflammatory cytokines and prostate-specific antigen in hyperplasia and human prostate cancer. Cancer Detect Prev. 2008;32:23-32.
Sato T, Terai M, Tamura Y, Alexeev V, Mastrangelo MJ, Selvan SR. Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy. J Immunol Res. 2011;51:170-182.
De Marzo AM, Platz EA, Sutcliffe S, et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer. 2007;7:256-269.
Silvestre GFG, De Lucena RP, Alves HDS. Cucurbitacins and the immune system: update in research on anti-inflammatory, antioxidant, and immunomodulatory mechanisms. Curr Med Chem. 2022;29:3774-3789.

Auteurs

Berlise Yengwa Bakam (BY)

Department of Animal Biology and Physiology, Faculty of Science, University of Yaoundé 1, Yaounde, Cameroon.

Judith Christiane Ngo Pambe (JCN)

Department of Morphological Sciences and Pathological Anatomy, Faculty of Medicine and Biomedical Sciences, University of Garoua, Garoua, Cameroon.

Timothy Grey (T)

Department of Urology and Pediatric Urology, University Medical Center Mainz, Johannes Gutenberg-Universität Mainz, Mainz, Germany.

Sebastian Maxeiner (S)

Department of Urology and Pediatric Urology, University Medical Center Mainz, Johannes Gutenberg-Universität Mainz, Mainz, Germany.

Jochen Rutz (J)

Department of Urology and Pediatric Urology, University Medical Center Mainz, Johannes Gutenberg-Universität Mainz, Mainz, Germany.

Dieudonne Njamen (D)

Department of Animal Biology and Physiology, Faculty of Science, University of Yaoundé 1, Yaounde, Cameroon.

Roman A Blaheta (RA)

Department of Urology and Pediatric Urology, University Medical Center Mainz, Johannes Gutenberg-Universität Mainz, Mainz, Germany.

Stéphane Zingue (S)

Department of Urology, University Hospital Frankfurt, Johann Wolfgang Goethe Universität, Frankfurt am Main, Germany.
Department of Pharmacotoxicology and Pharmacokinetics, Faculty of Medicine and Biomedical Sciences, University of Yaounde 1, Yaounde, Cameroon.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH